India’s drug regulator has ordered updated safety warnings for doxycycline and carbimazole after reviews flagged new adverse effects, aiming to better inform doctors and patients.
Hot this week
Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Get important news delivered directly to your inbox and stay connected!
